Self-Supervised Distillation of Legacy Rule-Based Methods for Enhanced EEG-Based Decision-Making
This provides a scalable, label-efficient solution for clinicians to localize epileptogenic zones more accurately, though it builds incrementally on existing self-supervised and VAE techniques.
The paper tackled the problem of detecting pathological high-frequency oscillations (HFOs) in intracranial EEG for epilepsy treatment, where traditional rule-based detectors have high false positive rates and supervised methods require scarce labeled data. The proposed SS2LD framework uses self-supervised learning with a VAE and clustering to refine legacy detector outputs, achieving state-of-the-art performance on multi-institutional datasets.
High-frequency oscillations (HFOs) in intracranial Electroencephalography (iEEG) are critical biomarkers for localizing the epileptogenic zone in epilepsy treatment. However, traditional rule-based detectors for HFOs suffer from unsatisfactory precision, producing false positives that require time-consuming manual review. Supervised machine learning approaches have been used to classify the detection results, yet they typically depend on labeled datasets, which are difficult to acquire due to the need for specialized expertise. Moreover, accurate labeling of HFOs is challenging due to low inter-rater reliability and inconsistent annotation practices across institutions. The lack of a clear consensus on what constitutes a pathological HFO further challenges supervised refinement approaches. To address this, we leverage the insight that legacy detectors reliably capture clinically relevant signals despite their relatively high false positive rates. We thus propose the Self-Supervised to Label Discovery (SS2LD) framework to refine the large set of candidate events generated by legacy detectors into a precise set of pathological HFOs. SS2LD employs a variational autoencoder (VAE) for morphological pre-training to learn meaningful latent representation of the detected events. These representations are clustered to derive weak supervision for pathological events. A classifier then uses this supervision to refine detection boundaries, trained on real and VAE-augmented data. Evaluated on large multi-institutional interictal iEEG datasets, SS2LD outperforms state-of-the-art methods. SS2LD offers a scalable, label-efficient, and clinically effective strategy to identify pathological HFOs using legacy detectors.